
Viatris, Pacira and the Return of Pain
Earlier today, Viatris agreed to acquire Pacira BioSciences for about $1.65 billion. Most coverage spins it
We have a range of services specifically tailored to the needs of business development and licensing pros:
We cover and comment on interesting news and trends in our industry

Earlier today, Viatris agreed to acquire Pacira BioSciences for about $1.65 billion. Most coverage spins it

From Pyramid to T, Part 3: What the T-Shaped Organization Means for BD Professionals

From Pyramid to T, Part 2: How to Get There, and What Has to
Collectively, we have decades of experience in consulting and business development. Let us bring this experience to help you solve your challenging in-licensing and out-licensing problems.